0001929737-22-000002.txt : 20220825 0001929737-22-000002.hdr.sgml : 20220825 20220825171159 ACCESSION NUMBER: 0001929737-22-000002 CONFORMED SUBMISSION TYPE: D/A PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20220825 DATE AS OF CHANGE: 20220825 EFFECTIVENESS DATE: 20220825 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Sustained Therapeutics Inc. CENTRAL INDEX KEY: 0001929737 IRS NUMBER: 000000000 STATE OF INCORPORATION: Z4 FILING VALUES: FORM TYPE: D/A SEC ACT: 1933 Act SEC FILE NUMBER: 021-446815 FILM NUMBER: 221198644 BUSINESS ADDRESS: STREET 1: 10TH FLOOR STREET 2: 595 HOWE STREET CITY: VANCOUVER STATE: A1 ZIP: V6C 2T5 BUSINESS PHONE: 778-388-3612 MAIL ADDRESS: STREET 1: 10TH FLOOR STREET 2: 595 HOWE STREET CITY: VANCOUVER STATE: A1 ZIP: V6C 2T5 D/A 1 primary_doc.xml X0708 D/A LIVE 0001929737 Sustained Therapeutics Inc. 10TH FLOOR 595 HOWE STREET VANCOUVER A1 BRITISH COLUMBIA, CANADA V6C 2T5 778-388-3612 CANADA (FEDERAL LEVEL) None None Corporation true Martin Gleave 10th Floor 595 Howe Street Vancouver A1 BRITISH COLUMBIA, CANADA V6C 2T5 Executive Officer Director Carol Ammon 10th Floor 595 Howe Street Vancouver A1 BRITISH COLUMBIA, CANADA V6C 2T5 Director Dennis Parolin 10th Floor 595 Howe Street Vancouver A1 BRITISH COLUMBIA, CANADA V6C 2T5 Director Other Health Care Decline to Disclose 06b true 0001929737-22-000001 2022-05-20 false true false 100000 100001 100001 0 false 1 0 0 0 In the ordinary course of business, the issuer may use some of the proceeds of the offering to pay salaries to certain of its executive officers and directors. false Sustained Therapeutics Inc. Dennis Parolin Dennis Parolin Director 2022-08-25